ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Takeda launches contract R&D firm

by Jean-François Tremblay
July 17, 2017 | APPEARED IN VOLUME 95, ISSUE 29

Takeda Pharmaceutical has opened a contract research firm, Axcelead, that provides drug discovery and development services to Takeda as well as other firms. Located in Kanagawa, Japan, near Tokyo, Axcelead is made up of assets and employees transferred from Takeda. It will offer preclinical services from basic research to compound optimization. Takeda says it spun off the company to increase the focus and productivity of its core research unit. In February, Takeda transferred some of its process chemistry and formulation development operations to Bushu Pharmaceuticals, a Japanese contract manufacturer.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment